ÂÜÀòÂÒÂ×

Michaela is an accomplished research scientist and translational leader with more than 15 years of interdisciplinary expertise spanning academia, biotech, and biopharma.

Throughout her career, she has been a pioneer in developing multidisciplinary research models to meet future precision medicine-driven drug discovery. Michaela has built fruitful research partnerships across a diverse oncology network with a proven strategic collaborative mindset at the intersection of clinical and pre-clinical studies, real-world molecular data, novel drug platforms, and next-gen disruptive technology. Additionally, she has had 60+ peer-reviewed publications across 10+ tumor segments spanning novel biological insights, biomarkers of drug response/resistance, clinical outcomes, and technology development.